[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539742":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":32,"responsibleParty":211,"collaborators":20,"id":213,"slug":20,"hasResults":214,"nctId":215,"briefTitle":216,"officialTitle":217,"acronym":20,"eligibilityCriteria":218,"healthyVolunteers":214,"sex":219,"minAge":220,"maxAge":20,"enrollmentInfo":221,"targetDuration":20,"studyType":224,"phases":225,"briefSummary":227,"conditions":228,"keywords":230,"overallStatus":35,"whyStopped":20,"lastUpdateSubmitDate":234,"lastUpdatePostDateStruct":235,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":243},{"fullName":5,"class":6},"Avistone Biotechnology Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ANS014004 Monotherapy","EXPERIMENTAL","Part 1 aims to determine the safety, tolerability, maximum tolerated dose (MTD) and\u002For recommended phase 2 dose (RP2D) of ANS014004.\n\nPart 2 aims to determine the safety, tolerability and evaluate anti-tumor activity of ANS014004 as monotherapy in select solid tumors.",[13],"Drug: ANS014004",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","ANS014004","Varying doses of ANS014004",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Medical Director Clinical Science","Beijing Avistone Biotechnology Co., Ltd.","STUDY_DIRECTOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Avistone Clinical Study Information Center","CONTACT","8610 84148921","information.center@avistonebio.com",[33,46,56,66,76,85,95,105,115,125,134,151,166,181,196],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":20},"University of California, San Diego","RECRUITING","San Diego","California","92093","United States",{"type":41,"coordinates":42},"Point",[43,44],-117.16472,32.71571,{"lat":44,"lon":43},{"facility":47,"status":35,"city":48,"state":49,"zip":50,"country":39,"cosmosGeoPoint":51,"geoPoint":55,"contacts":20},"Sarah Cannon Research Institute","Denver","Colorado","80218",{"type":41,"coordinates":52},[53,54],-104.9847,39.73915,{"lat":54,"lon":53},{"facility":57,"status":35,"city":58,"state":59,"zip":60,"country":39,"cosmosGeoPoint":61,"geoPoint":65,"contacts":20},"Advent Health","Orlando","Florida","32804",{"type":41,"coordinates":62},[63,64],-81.37924,28.53834,{"lat":64,"lon":63},{"facility":67,"status":35,"city":68,"state":69,"zip":70,"country":39,"cosmosGeoPoint":71,"geoPoint":75,"contacts":20},"Henry Ford Health Cancer","Detroit","Michigan","48202",{"type":41,"coordinates":72},[73,74],-83.04575,42.33143,{"lat":74,"lon":73},{"facility":77,"status":35,"city":78,"state":78,"zip":79,"country":39,"cosmosGeoPoint":80,"geoPoint":84,"contacts":20},"NYU Langone Health","New York","10003",{"type":41,"coordinates":81},[82,83],-74.00597,40.71427,{"lat":83,"lon":82},{"facility":86,"status":35,"city":87,"state":88,"zip":89,"country":39,"cosmosGeoPoint":90,"geoPoint":94,"contacts":20},"The University of Texas - MD Anderson Cancer Center","Houston","Texas","77030",{"type":41,"coordinates":91},[92,93],-95.36327,29.76328,{"lat":93,"lon":92},{"facility":96,"status":35,"city":97,"state":98,"zip":99,"country":39,"cosmosGeoPoint":100,"geoPoint":104,"contacts":20},"NEXT Oncology, Virginia","Fairfax","Virginia","22031",{"type":41,"coordinates":101},[102,103],-77.30637,38.84622,{"lat":103,"lon":102},{"facility":106,"status":35,"city":107,"state":108,"zip":109,"country":39,"cosmosGeoPoint":110,"geoPoint":114,"contacts":20},"Swedish Cancer Institute","Seattle","Washington","98195",{"type":41,"coordinates":111},[112,113],-122.33207,47.60621,{"lat":113,"lon":112},{"facility":116,"status":35,"city":117,"state":118,"zip":20,"country":119,"cosmosGeoPoint":120,"geoPoint":124,"contacts":20},"BC Cancer Vancouver Centre","Vancouver","British Columbia","Canada",{"type":41,"coordinates":121},[122,123],-123.11934,49.24966,{"lat":123,"lon":122},{"facility":126,"status":35,"city":127,"state":128,"zip":20,"country":119,"cosmosGeoPoint":129,"geoPoint":133,"contacts":20},"Princess Margaret Cancer Centre","Toronto","Ontario",{"type":41,"coordinates":130},[131,132],-79.39864,43.70643,{"lat":132,"lon":131},{"facility":135,"status":136,"city":137,"state":138,"zip":139,"country":140,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"Beijing Chest Hospital","NOT_YET_RECRUITING","Beijing","Beijing Municipality","101149","China",{"type":41,"coordinates":142},[143,144],116.39723,39.9075,{"lat":144,"lon":143},[147],{"name":148,"role":29,"phone":149,"phoneExt":20,"email":150},"Gen Lin","86-89509000","lingen@bjxkyy.cn",{"facility":152,"status":136,"city":153,"state":154,"zip":155,"country":140,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"Harbin Medical University Cancer Hospital","Harbin","Heilongjiang","150010",{"type":41,"coordinates":157},[158,159],126.65,45.75,{"lat":159,"lon":158},[162],{"name":163,"role":29,"phone":164,"phoneExt":20,"email":165},"Yan Yu","8645186298000","gpyuyan@163.com",{"facility":167,"status":136,"city":168,"state":169,"zip":170,"country":140,"cosmosGeoPoint":171,"geoPoint":175,"contacts":176},"Henan Cancer Hospital","Zhengzhou","Henan","450008",{"type":41,"coordinates":172},[173,174],113.64861,34.75778,{"lat":174,"lon":173},[177],{"name":178,"role":29,"phone":179,"phoneExt":20,"email":180},"Yanqiu ZHAO","400-0371-818","13938252350@163.com",{"facility":182,"status":136,"city":183,"state":184,"zip":185,"country":140,"cosmosGeoPoint":186,"geoPoint":190,"contacts":191},"Shandong Cancer Hospital","Jinan","Shandong","250117",{"type":41,"coordinates":187},[188,189],116.99722,36.66833,{"lat":189,"lon":188},[192],{"name":193,"role":29,"phone":194,"phoneExt":20,"email":195},"Yan Zhang","8653187984777","zhangyan0681@163.com",{"facility":197,"status":136,"city":198,"state":199,"zip":200,"country":140,"cosmosGeoPoint":201,"geoPoint":205,"contacts":206},"Shanghai Chest Hospital","Shanghai","Shanghai Municipality","200030",{"type":41,"coordinates":202},[203,204],121.45806,31.22222,{"lat":204,"lon":203},[207],{"name":208,"role":29,"phone":209,"phoneExt":20,"email":210},"Shun LU","86 21-222-00000","shun_lu@hotmail.com",{"type":212,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100539742",false,"NCT06307795","A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors","A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ANS014004 as a Single Agent in Participants With Locally Advanced or Metastatic Solid Tumors","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Eastern Cooperative Oncology Group (ECOG) Performance Status: 0-1\n* Life expectancy ≥ 12 weeks\n* Measurable disease per RECIST v1.1\n* Adequate organ and marrow function as defined in the protocol\n* With a pathogenetic MET alteration or ROS1 alteration or NTRK alternation\n\nExclusion Criteria:\n\n* Active infection including tuberculosis and HBV, HCV or HIV\n* Known active or untreated CNS metastases\n* Participants with carcinomatous meningitis or meningeal metastases, or spinal cord compression\n* Participants with serious cardiovascular or cerebrovascular diseases","ALL","18 Years",{"count":222,"type":223},63,"ESTIMATED","INTERVENTIONAL",[226],"PHASE1","This is a Phase 1, first-in-human, open-label, multi-center study with the aim of exploring the safety, tolerability, PK, and preliminary anti-tumor activity of ANS014004 as a single agent in participants with locally advanced or metastatic solid tumors.",[229],"Locally Advanced or Metastatic Solid Tumors",[231,232,233],"ROS1","NTRK","ROS1\u002FNTRK","2026-04-15",{"date":236,"type":237},"2026-04-17","ACTUAL",{"date":239,"type":237},"2024-06-24",{"date":241,"type":223},"2027-10",{"name":5,"class":6},15]